Clinical Trials
6 trialsNCT01570296 2023-03-29
BKM120
National Cancer Centre, Singapore
Phase 1 Completed
NCT01626209 2020-12-09
A Phase I Study of BKM120 in Adult Chinese Patients With Advanced Solid Tumors
Novartis
Phase 1 Completed
NCT02128724 2019-08-01
BKM120
University of Oxford
Phase 1 Completed
NCT01487265 2019-03-06
Trial of Erlotinib and BKM120 in Patients With Advanced Non Small Cell Lung Cancer Previously Sensitive to Erlotinib
SCRI Development Innovations, LLC
Phase 2 Completed
NCT01723800 2016-09-20
PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer
City of Hope Medical Center
Phase 1 Completed
NCT01297491 2016-03-11
BASALT-1
Novartis
Phase 2 Completed